Actinogen Medical Limited

Actinogen Medical Limited - Enterprise Valueverified

ATGGF

Price:

$0.0008

Market Cap:

$156.13M

Actinogen Medical Limited is an Australian biotechnology firm specializing in the creation of treatments for neurological and neuropsychiatric conditions linked to abnormal brain cortisol levels. Their primary therapeutic candidate, Xanamem, functions as an inhibitor of the 11ß-HSD1 enzyme. Currently in Phase 2 clinical trials, Xanamem has shown the ability to engage its intended target within the central nervous system. Its development focuses on addressing Alzheimer's disease, cognitive impairment associated with depression, and the anxiety, sleep, and behavioral challenges seen in fragile X syndrome. Founded in 1999, the company, based in Sydney, Australia, operated as Actinogen Limited u...[Read more]

Industry

Biotechnology

IPO Date

2018-09-18

Stock Exchange

OTC

Ticker

ATGGF

The Enterprise Value as of August 2026 (TTM) for Actinogen Medical Limited (ATGGF) is 149.97M

According to Actinogen Medical Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 149.97M. This represents a change of 65.47% compared to the average of 90.63M of the last 4 quarters.

Actinogen Medical Limited (ATGGF) Historical Enterprise Value (quarterly & annually)

How has ATGGF Enterprise Value performed in the past?

The mean historical Enterprise Value of Actinogen Medical Limited over the last ten years is 60.84M. The current 149.97M Enterprise Value has changed 24.55% with respect to the historical average. Over the past ten years (40 quarters), ATGGF's Enterprise Value was at its highest in in the December 2021 quarter at 261.95M. The Enterprise Value was at its lowest in in the December 2024 quarter at -21846962.88.

Quarterly (TTM)
Annual

Average

60.84M

Median

48.80M

Minimum

2.60M

Maximum

166.99M

Actinogen Medical Limited (ATGGF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Actinogen Medical Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 751.58%

Maximum Annual Enterprise Value = 166.99M

Minimum Annual Increase = -88.94%

Minimum Annual Enterprise Value = 2.60M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202555.30M-58.17%
2024132.20M110.83%
202362.70M-8.43%
202268.48M-58.99%
2021166.99M751.58%
202019.61M655.08%
20192.60M-88.94%
201823.49M-32.41%
201734.75M-17.86%
201642.30M117.13%

Actinogen Medical Limited (ATGGF) Average Enterprise Value

How has ATGGF Enterprise Value performed in the past?

The current Enterprise Value of Actinogen Medical Limited (ATGGF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

83.40M

5-year avg

97.13M

10-year avg

60.84M

Actinogen Medical Limited (ATGGF) Enterprise Value vs. Peers

How is ATGGF’s Enterprise Value compared to its peers?

Actinogen Medical Limited’s Enterprise Value is greater than Nicox S.A. (26.75M), less than Clara Technologies Corp. (11.24B), greater than Vicapsys Life Sciences, Inc. (47.43M), greater than IXICO plc (6.33M), greater than Alterity Therapeutics Limited (65.16M), greater than ZIVO Bioscience, Inc. (16.32M), greater than BioStem Technologies, Inc. (46.20M), less than MindMaze Therapeutics Holding S.A. (0), greater than Amplia Therapeutics Limited (49.48M), greater than Helix BioPharma Corp. (115.14M),

Build a custom stock screener for Actinogen Medical Limited (ATGGF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actinogen Medical Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Actinogen Medical Limited (ATGGF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Actinogen Medical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Actinogen Medical Limited's Enterprise Value?

What is the highest Enterprise Value for Actinogen Medical Limited (ATGGF)?

What is the 3-year average Enterprise Value for Actinogen Medical Limited (ATGGF)?

What is the 5-year average Enterprise Value for Actinogen Medical Limited (ATGGF)?

How does the current Enterprise Value for Actinogen Medical Limited (ATGGF) compare to its historical average?